Inogen
Logotype for Inogen Inc

Inogen (INGN) investor relations material

Inogen Q3 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Inogen Inc
Q3 2026 earnings summary5 Nov, 2026

Executive summary

  • Q3 continuing-operations revenue was $77.193M, down 2.4% YoY; adjusted net loss was $0.4M versus adjusted earnings of $1.2M a year earlier.

  • U.S. sales returned to YoY growth for the first time since Q4 2024, while lower international sales offset the increase.

  • Andy Reding became President and CEO; priorities include commercial execution, growth products, and disciplined costs.

  • The U.S. oxygen rental business was sold after quarter-end, with a post-sale program targeting $20M in annualized savings by end-2027.

Financial highlights

  • Q3 revenue was $77.193M versus $79.090M a year earlier; constant-currency revenue declined 3.2%.

  • GAAP loss from continuing operations was $14.794M versus $3.6M in Q3 2025, including a $10.559M non-cash goodwill impairment.

  • Adjusted diluted loss per share was $0.02 versus adjusted earnings per share of $0.04; adjusted operating loss was $1.2M versus $0.6M.

  • Nine-month revenue rose 2.8% to $233.122M; GAAP loss from continuing operations was $25.4M and adjusted loss was $2.9M.

  • Q3 operating cash flow was negative $4.5M due to higher working capital; nine-month continuing-operations cash used was $13.610M, improved from $20.398M.

Outlook and guidance

  • Q4 2026 continuing-operations revenue guidance is $65M-$68M; FY 2026 guidance is $298M-$301M.

  • FY 2026 adjusted loss from continuing operations is expected to be $7M-$8M; adjusted net earnings replaces adjusted EBITDA after the divestiture.

  • International softness is expected to continue into Q4, with U.S. growth projected to accelerate and offset some weakness.

  • Savings program targets ~$20M annualized, with about half expected in Q4 2026 and the balance during 2027; substantial completion is expected by end-2027.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Inogen earnings date

Logotype for Inogen Inc
Q4 202624 Feb, 2027
Inogen
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next Inogen earnings date

Logotype for Inogen Inc
Q4 202624 Feb, 2027

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

Inogen Inc. specializes in the development, manufacturing, and marketing of portable oxygen concentrators (POCs) for patients with chronic respiratory conditions. The company’s products are designed to provide mobility and independence for individuals requiring supplemental oxygen therapy. Inogen offers its concentrators directly to consumers, through distributors, and via rental programs, serving patients worldwide. The company is headquartered in Goleta, California, and its shares are listed on the NASDAQ.